首页> 美国卫生研究院文献>Frontiers in Pharmacology >Effect of Acetaminophen Ingestion on Thermoregulation of Normothermic Non-febrile Humans
【2h】

Effect of Acetaminophen Ingestion on Thermoregulation of Normothermic Non-febrile Humans

机译:摄入对乙酰氨基酚对常温非发热人体温调节的影响

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

In non-febrile mouse models, high dose acetaminophen administration causes profound hypothermia. However, this potentially hazardous side-effect has not been confirmed in non-febrile humans. Thus, we sought to ascertain whether an acute therapeutic dose (20 mg⋅kg lean body mass) of acetaminophen would reduce non-febrile human core temperature in a sub-neutral environment. Ten apparently healthy (normal core temperature, no musculoskeletal injury, no evidence of acute illness) Caucasian males participated in a preliminary study (Study 1) to determine plasma acetaminophen concentration following oral ingestion of 20 mg⋅kg lean body mass acetaminophen. Plasma samples (every 20 min up to 2-hours post ingestion) were analyzed via enzyme linked immunosorbent assay. Thirteen (eight recruited from Study 1) apparently healthy Caucasian males participated in Study 2, and were passively exposed to 20°C, 40% r.h. for 120 min on two occasions in a randomized, repeated measures, crossover design. In a double blind manner, participants ingested acetaminophen (20 mg⋅kg lean body mass) or a placebo (dextrose) immediately prior to entering the environmental chamber. Rectal temperature, skin temperature, heart rate, and thermal sensation were monitored continuously and recorded every 10 min. In Study 1, the peak concentration of acetaminophen (14 ± 4 μg/ml) in plasma arose between 80 and 100 min following oral ingestion. In Study 2, acetaminophen ingestion reduced the core temperature of all participants, whereas there was no significant change in core temperature over time in the placebo trial. Mean core temperature was significantly lower in the acetaminophen trial compared with that of a placebo (p < 0.05). The peak reduction in core temperature in the acetaminophen trial was reached at 120 min in six of the thirteen participants, and ranged from 0.1 to 0.39°C (average peak reduction from baseline = 0.19 ± 0.09°C). There was no significant difference in skin temperature, heart rate, or thermal sensation between the acetaminophen and placebo trials (p > 0.05). The results indicate oral acetaminophen reduces core temperature of humans exposed to an environment beneath the thermal neutral zone. These results suggest that acetaminophen may inhibit the thermogenic mechanisms required to regulate core temperature during exposure to sub-neutral environments.
机译:在非发热小鼠模型中,高剂量对乙酰氨基酚给药会引起严重的体温过低。但是,尚未在非发热人群中证实这种潜在的有害副作用。因此,我们试图确定对乙酰氨基酚的急性治疗剂量(20 mg·kg瘦体重)是否会降低亚中性环境中非发热性人的核心温度。十名表面健康的人(正常的体温,无肌肉骨骼损伤,无急性疾病的证据),白人男性参加了一项初步研究(研究1),以口服摄入20 mg·kg瘦体重的对乙酰氨基酚后测定血浆对乙酰氨基酚的浓度。通过酶联免疫吸附测定法分析血浆样品(摄入后每20分钟至2小时)。 13名(研究1中招募了8名)表面健康的白种男性参加了研究2,并被动暴露于20°C,40%r.h的条件下。随机,重复测量,交叉设计两次,每次120分钟。以双盲方式,参与者在进入环境室之前立即摄入对乙酰氨基酚(20 mg·kg瘦体重)或安慰剂(葡萄糖)。连续监测直肠温度,皮肤温度,心率和热感,并每10分钟记录一次。在研究1中,口服后80至100分钟之间血浆中对乙酰氨基酚的峰值浓度(14±4μg/ ml)出现。在研究2中,对乙酰氨基酚的摄入降低了所有参与者的体温,而在安慰剂试验中,体温没有随时间的显着变化。对乙酰氨基酚试验的平均核心温度显着低于安慰剂组(p <0.05)。对乙酰氨基酚试验的核心温度峰值降低在13分钟中的六名参与者在120分钟时达到,范围从0.1到0.39°C(从基线的平均峰值降低= 0.19±0.09°C)。对乙酰氨基酚试验和安慰剂试验之间的皮肤温度,心率或热感无显着差异(p> 0.05)。结果表明口服对乙酰氨基酚可降低暴露于热中性区以下环境的人类的核心温度。这些结果表明,对乙酰氨基酚可能会抑制在暴露于中性环境下调节核心温度所需的生热机制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号